Results 221 to 230 of about 262,716 (337)

Prognostic Implications of Comprehensive Whole Vessel Plaque Quantification Using Coronary Computed Tomography Angiography

, 2021
Seokhun Yang, Joo Myung Lee, Masahiro Hoshino, Tadashi Murai, Ki Hong Choi, Doyeon Hwang, Kyung-Jin Kim, Eun‐Seok Shin, Joon‐Hyung Doh, Hyuk‐Jae Chang, Chang‐Wook Nam, Jinlong Zhang, Jianan Wang, Shao‐Liang Chen, Nobuhiro Tanaka, Hitoshi Matsuo, Takashi Akasaka, Tsunekazu Kakuta, Bon‐Kwon Koo   +18 more
openalex   +1 more source

A Prospective, Multicenter, Open Label Study Investigating the Implementation of a Standardized Algorithm for Coronary CaLcificatiOn With PlaquE Modification Using UltraSound Guidance to Improve Procedural and Clinical Outcomes (CYCLOPES): Design and Rationale of the CYCLOPES Trial

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Introduction Moderate‐to‐severe calcification is present in ~20%–30% of patients undergoing coronary angiography. Coronary lesion modification is often necessary to facilitate optimal stent delivery and expansion, with several dedicated devices now approved for calcium modification before stent implantation. The CYCLOPES study aims to evaluate
Daniel O'Callaghan, Rory Durand, Colm G. Hanratty, Thomas Cuisset, Beatriz Vaquerizo, Jan‐Malte Sinning, Peter O'Kane, J. J. Coughlan, Simon Walsh, Róisín Colleran, Himanshu Rai, Osama Soliman, Emanuele Barbato, Barbara E. Stähli, Robert A. Byrne   +14 more
wiley   +1 more source

Liberation of vessel-adherent myeloperoxidase reflects plaque burden in patients with stable coronary artery disease [PDF]

, 2013
Tanja K. Rudolph, Anna Klinke, D. Lau, Ralf Koester, T. Meinertz, Stephan Baldus, Volker Rudolph   +6 more
openalex   +1 more source

COMPARATIVE ANALYSIS OF OUTCOME AFTER MEDICAL THERAPY ALONE VERSUS INCOMPLETE REVASCULARIZATION ALONG WITH MEDICAL THERAPY IN PATIENTS WITH MULTI-VESSEL CORONARY ARTERY DISEASE

, 2023
K MAHMOOD, Imran Javaid, O ADEEB, Kashif Ali Hashmi   +3 more
openalex   +2 more sources

Nationwide Analysis of PCI After TAVR From the Netherlands Heart Registration

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Percutaneous coronary intervention (PCI) after transcatheter aortic valve replacement (TAVR) has gained interest as concomitant coronary artery disease (CAD) is now often treated conservatively before TAVR, and TAVR is increasingly used in younger patients with longer life expectancies. Therefore, more contemporary data on PCI after
Hugo M. Aarts, Kimberley I. Hemelrijk, Gijs M. Broeze, Steven A. Muller, Lineke Derks, Ronak Delewi, Michiel Voskuil, the Transcatheter Heart Intervention and Percutaneous Coronary Intervention registration committees of the Netherlands Heart Registration   +7 more
wiley   +1 more source

P150Effects of oxygen administration during CMR imaging in patients with multi-vessel coronary artery disease [PDF]

, 2019
Dominik P. Guensch, Kady Fischer, Kyohei Yamaji, Y Ueki, Bernd Jung, Lorenz Räber, H Von Kobligk-Tengg, Balthasar Eberle   +7 more
openalex   +1 more source

Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy Participants

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Asciminib is the first BCR::ABL1 inhibitor that Specifically Targets the ABL Myristoyl Pocket (STAMP) in patients with chronic myeloid leukemia. This phase 1, two‐treatment‐period, drug‐drug interaction study evaluated the effect of steady‐state asciminib on the pharmacokinetics of atorvastatin.
Matthias Hoch, Wendy Weis, Felix Huth, Seshulatha Jamalapuram, Michelle Quinlan, Amarnath Bandaru, Suleyman Eralp Bellibas, Asmae Mirkou, Shruti Kapoor, Shefali Kakar   +9 more
wiley   +1 more source

Role of electrocardiogram in identification of culprit vessel occlusion in acute ST elevation myocardial infarction in relation to coronary angiography

, 2017
RajeshJ Khyalappa, KunalK Salunke
openalex   +1 more source

Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer (IATRO), Results from a Nationwide Emulated Clinical Trial

Clinical Pharmacology &Therapeutics, EarlyView.
Antiangiogenic therapy with bevacizumab improves outcomes in ovarian cancer but induces hypertension, leading to major adverse cardiovascular events (MACE). While calcium channel blockers (CCBs) and angiotensin‐converting enzyme inhibitors (ACEi) are recommended for managing bevacizumab‐associated hypertension, their impacts on cancer progression and ...
Floriane Jochum, Élise Dumas, Joe‐Elie Salem, Stéphane Ederhy, Anne‐Sophie Hamy, Lise Lecointre, Enora Laas, Fabien Reyal, Fabrice Lecuru, Cherif Akladios, Paul Gougis   +10 more
wiley   +1 more source

Great Saphenous Vein Lumen: Intimal Openings. [PDF]

Braz J Cardiovasc Surg
Loesch A.
europepmc   +1 more source